7p22.1 microduplication syndrome: Clinical and molecular characterization of an adult case and review of the literature

https://doi.org/10.1016/j.ejmg.2015.08.003Get rights and content

Abstract

A new 7p22.1 microduplication syndrome characterized by intellectual disability, speech delay and craniofacial dysmorphisms, such as macrocephaly, hypertelorism and ear anomalies, has been outlined by the description of two patients with interstitial microduplications confined to 7p22.1 and the recently defined minimal overlapping 430 kb critical region including five genes. Here we report on the first adult patient aged 35 years with moderate intellectual disability, psychomotor delay, facial dysmorphisms, cryptorchidism and cardiac anomalies, who carries two close microduplications at 7p22.1 of about 900 and 150 kb, respectively. The proximal smaller duplication includes three coding genes and maps outside the minimal described overlapping duplicated region, while the larger one represents the smallest 7p22.1 microduplication reported so far, as it encompasses the entire minimal region with only four additional genes. We compare the phenotype of our patient with that of the few reported cases and discuss on candidate genes in order to enhance the knowledge on genotype–phenotype correlation in 7p22.1 duplication syndrome.

Introduction

Duplications of the short arm of chromosome 7 are a relatively rare finding. Most of them are complex rearrangements resulting from a differently sized and positioned parental balanced translocation or inversion (for review see Papadopoulou et al., 2006). Only a few patients with pure 7p duplications have been reported, including sixteen cases detected by standard cytogenetic analysis (Papadopoulou et al., 2006). The common clinical signs include intellectual disability (ID), hypotonia, craniofacial dysmorphism (large anterior fontanel, high and/or broad forehead, ocular hypertelorism, downslanting palpebral fissures, low set and/or malformed ears, abnormal palate, micrognathia and/or retrognathia), abnormal palmar creases, skeletal and cardiovascular abnormalities. Later on only five 7p microduplications detected by array-CGH have been characterized. All of them, except for the approximately 5 Mb microduplication involving the terminal region (Zahed et al., 2007), are interstitial microduplications located in the 7p22 band (AlFardan et al., 2011, Chui et al., 2011, Pebrel-Richard et al., 2014, Preiksaitiene et al., 2012). Interestingly, the 2.4 Mb duplication spanning 7p22.1p22.2 reported in an 11 year-old female with a “classic 7p duplication phenotype” was inherited from the mother who presented only with some facial features in common with her daughter and mild cognitive disability (AlFardan et al., 2011). The de novo 1.7 Mb 7p22.1 duplication detected by Chui et al. in a 28 month-old male patient was associated with a clinical phenotype characterized by speech delay, the typical dysmorphic features of 7p duplication, and skeletal anomalies (Chui et al., 2011). The 1 Mb duplication involving 7p22.1 described by Preiksaitiene et al. is the smallest reported up to date (Preiksaitiene et al., 2012). The carrier was a 14 year-old patient with mild ID, psychomotor delay, moderate hydrocephalus, several craniofacial dysmorphic features, skeletal anomalies and truncal obesity. Given that 7p22.1 microduplications are associated with common clinical features recorded in patients with larger duplications as well, the region indicated by Preiksaitiene et al. (2012) has been proposed as critical for a 7p22.1 recognizable microduplication syndrome which hallmarks are developmental delay, distinctive facial features and skeletal anomalies. More recently, Pebrel-Richard et al. has described a 3 year-old boy carrying a 7p22.2p22.1 microduplication of about 1.6 Mb who displayed psychomotor and speech delay, several craniofacial dysmorphisms typical of 7p duplication plus joint hypermobility, truncal stereotypies and attention deficit disorder (ADD) (Pebrel-Richard et al., 2014). This microduplication partially overlaps with the smallest duplicated region reported by Preiksaitiene et al. (2012), allowing to highlight a minimal critical region of 430 kb encompassing five genes: TNRC18, FBXL18, ACTB, FSCN1 and RNF216.

We report on the aCGH characterization of an adult patient carrying the smallest 7p22.1 microduplication detected so far, and compare his phenotype to that of the previously described patients subject to cytogenomic investigation.

Section snippets

Clinical report

The patient was the third child of non-consanguineous parents, with two healthy elder sisters. Six miscarriages were recorded but no analyses were performed on the parents to investigate a possible genetic cause. His father, who suffered from stuttering, died of acute pancreatitis. His mother is affected by type 2 diabetes. A first cousin on the mother side presented deafness, coloboma, facial asymmetry (left < right), and right renal pelvic dilation. These features are suggestive of CHARGE or

Molecular cytogenetic characterization

Previous genetic analyses (karyotype, subtelomeric FISH, Fragile X test) were normal. Since the clinical features and the facial appearance were consistent with a congenital disease, array-CGH was performed using the SurePrint G3 Human CGH Microarray kit 8x60K (Agilent Technologies, Santa Clara, CA). Two close microduplications were detected at 7p22.1 and confirmed and more precisely defined by means of the higher resolution 400K platform (Agilent Technologies, Santa Clara, CA). According to

Discussion

We describe the first adult patient with two close 7p22.1 microduplications of 886 kb and 156 kb, respectively. The distal larger microduplication is the smallest reported so far, and fully encompasses the minimal region of 430 kb highlighted by Pebrel-Richard et al. as critical of this newly described syndrome (Fig. 4; Pebrel-Richard et al., 2014, Preiksaitiene et al., 2012). The emerging phenotype of the reported patients carrying microduplications involving this region, whose age ranges from

Acknowledgements

We gratefully acknowledge the patient's family for giving its consent to publish clinical data and photos. This work was supported by Ricerca corrente 08C803_2008 to IAI.

References (16)

  • P.L. Greer et al.

    The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc

    Cell

    (2010 Mar 5)
  • A.M. Mabb et al.

    Triad3A regulates synaptic strength by ubiquitination of arc

    Neuron

    (2014 Jun 18)
  • J. AlFardan et al.

    Small duplication of chromosome (7)(p22.1p22.2) and consideration of a dup 7p syndrome critical region

    Clin. Dysmorphol.

    (2011 Oct)
  • J.S. Berg et al.

    Common recurrent microduplication syndromes: diagnosis and management in clinical practice

    Am. J. Med. Genet. A

    (2010 May)
  • J.V. Chui et al.

    Clinical and molecular characterization of chromosome 7p22.1 microduplication detected by array CGH

    Am. J. Med. Genet. A

    (2011 Oct)
  • J. Douglas et al.

    Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth

    Nat. Genet.

    (2007 Aug)
  • S. Kühnle et al.

    Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein arc

    Proc. Natl. Acad. Sci. U. S. A.

    (2013 May 28)
  • J. Nevado et al.

    PIAS4 is associated with macro/microcephaly in the novel interstitial 19p13.3 microdeletion/microduplication syndrome

    Eur. J. Hum. Genet.

    (2015 Apr 8)
There are more references available in the full text version of this article.

Cited by (8)

  • 1p31.1 microdeletion including only NEGR1 gene in two patients

    2020, European Journal of Medical Genetics
    Citation Excerpt :

    Ronzoni et al. hypothesized that RNF216 could be responsible for the phenotypic features of their patient and probably for the individuals, reported in the DECIPHER database, that exhibit delayed speech and language development, macrocephaly (249575, 290018), severe intellectual disability (288866) or autism (289585) (Fig. 3) (Table 2). A similar hypothesis has been made for macrocephaly and autism (Caselli et al., 2015; Goitia et al., 2015). Our patient 2 presents with a variety of phenotypic features characteristic of both a deficiency of NEGR1 and duplication of RNF216.

  • Refinement of the critical 7p22.1 deletion region: Haploinsufficiency of ACTB is the cause of the 7p22.1 microdeletion-related developmental disorders

    2018, European Journal of Medical Genetics
    Citation Excerpt :

    Heterozygous mutations in ACTB have been recently associated with Baraitser-Winter syndrome (BRWS, OMIM 243310), a rare autosomal dominant developmental disorder characterized by the combination of craniofacial dysmorphic features, brain malformations, intellectual disability, developmental delay, and intractable seizures (Verloes et al., 2015). In addition, duplication of ACTB has recently been described in literature as cause of a new recognizable 7p22.1 microduplication syndrome with hallmarks of developmental delay, speech delay, facial dysmorphisms, and skeletal abnormalities (Chui et al., 2011; Preiksaitiene et al., 2012; Pebrel-Richard et al., 2014; Caselli et al., 2015; Goitia et al., 2015; Ronzoni et al., 2017). According to DECIPHER database, the haploinsufficiency index for ACTB is 1.03% indicating that not only the point mutations or microduplication but also its deletion could lead deleterious effect (Huang et al., 2010).

  • 7p22.1 microduplication syndrome: Refinement of the critical region

    2017, European Journal of Medical Genetics
    Citation Excerpt :

    Homozygous or compound heterozygous mutations in RNF216 cause Gordon Holmes Syndrome (OMIM #212840), which is characterized by cerebellar ataxia and hypogonadotropic hypogonadism (Seminara et al., 2002). It has recently been speculated that the RNF216 dosage effect might contribute to the neurological phenotype in patients with 7p22.1 duplications because the Rnf216 protein is a regulator of synaptic strength (Caselli et al., 2015). The dosage effect hypothesis of RNF216 is also supported by four patients in the Decipher Database who carry a 7p22.1 microduplication that overlaps with the minimal critical region only for RNF216 gene (patients 249575, 290018, 288866, and 289585).

  • 7p22.1 microdeletions involving ACTB associated with developmental delay, short stature, and microcephaly

    2016, European Journal of Medical Genetics
    Citation Excerpt :

    It therefore follows that loss-of-function, or haploinsufficiency, of ACTB may have similar, but different, phenotypic consequences as dominant negative mutations. Although there are no reports of patients with microdeletions involving the 7p22.1 region, microduplications in this region have been reported [Papadopoulou et al., 2006; Chui et al., 2011; Preiksaitiene et al., 2012; Pebrel-Richard et al., 2014; Caselli et al., 2015; Goitia et al., 2015]. Most patients with 7p22.1 microduplications show non-specific developmental delay and craniofacial abnormalities.

View all citing articles on Scopus
View full text